Refinitiv StreetEvents Event Transcript
E D I T E D V E R S I O N
IBRX.OQ - Immunitybio Inc
Immunitybio Inc Business Update and Review Financial Results for Full Year 2025
Mar 03, 2026 / 09:30PM GMT
=====================
Presentation
--------------------------------------------------------------------------------
Unidentified_1 [1]
--------------------------------------------------------------------------------
Good afternoon and welcome to Immunitybio's full year 2025 earnings conference call. At this time, all participants are in a listen-only mode. Following the prepared remarks, we will conduct a question-and-answer session. To ask a question, please press the key on your one key on your touchstone phone. Please be advised that today's call is being recorded and a replay will be available on the investor relations section of Immunitybio's website.
Before we begin, I'd like to remind you that this presentation and accompanying discussion will contain forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1,995. All statements other than statements of
